The health secretary Alan Johnson has defended his decision to carry out a once-in-a-generation reform of the NHS in England.He …
The government is to ask the NHS managers to look again at using the private sector to improve primary care …
Cervarix, the cervical cancer vaccine from GlaxoSmithKline has received a positive opinion from the European medicines regulator, meaning it could …
Lilly has opened a new extension to its UK drug research laboratories which specialise in new medicines for neurological conditions.The …
Affiris begins clinical testing of Alzheimer's vaccineAffiris' Alzheimer's vaccine Affitope has now entered the clinical phase of its development and …
How many times do you come across that old cliche about an emotional rollercoaster? It seems to be applied to …
Sales of Pfizer's flagship brand Lipitor suffered in the second quarter, contributing to a 20% drop in profits.The company began …
A woman with bowel cancer has won her High Court battle for access to the drug Avastin, overturning a decision …
Specialist pharma company Actelion has registered a loss of 53 million Swiss francs ($44 million) for the first half of …
Roche's Franz Humer is stepping down as chief executive to concentrate on his role as chairman.In splitting the top jobs, …
Swiss pharma company Novartis has posted sales growth of 14% for the first half of 2007, but growing pressure from …
UK Alzheimer's patients may not lose access to drug treatment, despite restrictive NICE guidance.Prescribing of Alzheimer's drugs has increased by …
Bayer has officially launched its new UK pharmaceutical division, following last year's acquisition of Schering Health Care.Called Bayer Schering Pharma, …
After 18 months of deliberation by an expert committee, the UK government has agreed in principle that girls aged 12-13 …
A patient group is urging doctors to exercise their clinical judgement to overrule NICE guidance which restricts access to Alzheimer's …
An unprecedented legal action by the pharmaceutical industry against the government could reach the High Court within the next few …
Antisoma drops ovarian cancer drugCancer drug developer Antisoma says new data from its Phase II trial of ASA404 showed that …
There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …
A review of the NHS in London has recommended setting up a network of 150 'polyclinics' to take on much …
The FDA has approved Novartis' Exelon Patch, the first ever skin patch treatment for Alzheimer's disease.Novartis said the once-daily treatment …